Control of nocturnal gastric acidity: A role for low dose bedtime ranitidine to supplement daily omeprazole

Digestive Diseases and Sciences

Volumn 47, Issue 2, 2002, Pages 265-273

  Robinson, Malcolm ^a   Rodriguez Stanley, Sheila ^a   Ciociola, Arthur A ^b   Filinto, Jonathan ^a   Zubaidi, Sattar ^a   Miner Jr, Philip B ^a   Gardner, Jerry D ^c  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b PFIZER INC   (United States)

^c Science for Organizations Inc   (United States)

Author keywords

Gastric secretion; GERD; H2 RAs; Heartburn; Integrated acidity; PPI's

Indexed keywords

OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; STOMACH SECRETION INHIBITOR;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG INDICATION; DRUG MIXTURE; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MALE; NIGHT; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; STOMACH PH;

ANTI-ULCER AGENTS; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OMEPRAZOLE; RANITIDINE; SINGLE-BLIND METHOD;

EID: 0036159244     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013749501241     Document Type: Article

References (26)

1. Ambulatory 24-H esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility
2. 24-H pH monitoring for gastroesophageal reflux disease: Already standard but not yet gold?
3. Appropriate acid suppression for the management of gastroesophageal reflux disease
4. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease
5. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease
6. Gastro-oesophageal reflux disease
7. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects
8. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors
9. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors
10. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily
11. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH
12. Heartburn/stomach symptoms during chronic proton pump inhibitor therapy: Evidence for occasional symptom breakthrough
13. The determination of gastric acidity by the glass electrode
14. Undissociated acidity of human gastric juice
15. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: A comparative study with cimetidine and placebo
16. Integrated acidity and the pathophysiology of GERD
17. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis
18. Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls
19. Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls
20. Gastric acid hypersecretion in gastroesophageal reflux disease
21. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus
22. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease
23. Gastric acid secretion rate and buffer content of the stomach after eating
24. Total 24-hour gastric acid secretion in patients with duodenal ulcer
25. A quantitative statement of the two-component hypothesis of gastric secretion
26. Motor functions of the pharynx and esophagus